WAG
GILD icon

Winthrop Advisory Group’s Gilead Sciences GILD Stock Holding History

Winthrop Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
2,429
+497
+26% +$65.5K 0.02% 167
2026
Q1 		$269K Buy
1,932
+7
+0.4% +$980 0.02% 157
2025
Q4 		$236K Buy
1,925
+32
+2% +$3.89K 0.02% 167
2025
Q3 		$210K Hold
1,893
– – 0.02% 182
2025
Q2 		$210K Hold
1,893
– – 0.02% 168
2025
Q1 		$212K Buy
+1,893
New +$195K 0.03% 144
2022
Q1 		– Sell
-2,963
Closed -$215K – 142
2021
Q4 		$215K Hold
2,963
– – 0.04% 133
2021
Q3 		$207K Buy
+2,963
New +$208K 0.05% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Winthrop Advisory Group's GILD Position: Q2 2026 in Review

Winthrop Advisory Group increased its Gilead Sciences (GILD) stake by 26% in Q2 2026, buying an estimated $65.5K and bringing the position to 2,429 shares worth $307K. The position accounts for 0.02% of the portfolio, ranked #167.

Winthrop Advisory Group first reported a position in GILD in Q3 2021 and has held it in 8 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Winthrop Advisory Group held 2,429 shares of Gilead Sciences worth $307K as of Q2 2026.
  • Winthrop Advisory Group bought 497 Gilead Sciences shares in Q2 2026, an estimated $65.5K.
  • Gilead Sciences made up 0.02% of Winthrop Advisory Group's portfolio in Q2 2026, its #167 holding.
  • Winthrop Advisory Group first reported a position in Gilead Sciences in Q3 2021 and has held it in 8 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Winthrop Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.